Latest News

Neurodegenerative disease advance: Study details how brain enzyme interacts with drug-like lead compound for Huntington's

A significant breakthrough has been made towards developing an effective treatment for neurodegenerative diseases such as Huntington's, Alzheimer's and Parkinson's. Researchers have detailed how an enzyme in the brain interacts with a promising drug-like lead compound for Huntington's disease to inhibit its activity. Their findings demonstrate that it can be developed as an effective treatment for neurodegenerative diseases.
View full story

Post your comment.

Name:
Email:
Rating:
Comment:
Verification
 

  • Veterans generally satisfied with mental health care, study shows

  • Intervention helps smokers quit following hospital stay

  • Employee-retention practices challenged by experts

  • Recovery reversal seen in study of returning concussed athletes

  • Colds and other common infections tied to some stroke risk in kids

  • Striatum acts as hub for multisensory integration

  • Forensics research to make cadaver dogs more efficient

  • Study Identifies Challenges Faced by NYU Langone Nurses in the Aftermath of Hurricane Sandy

  • Creating pomegranate drug to stem Alzheimer's, Parkinson's

  • In our digital world, are young people losing the ability to read emotions?

  •